Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): rise in arterial stiffness associates with HFpEF with increase in comorbidities.
Event: ESC Congress 2021 - The Digital Experience
Topic: Pathophysiology
Session: Congress committee e-posters choice in heart failure
Sacubitril/valsartan (SV) in chronic symptomatic heart failure with reduced ejection fraction; early clinical experience from a large UK tertiary centre.
Event: Heart Failure 2018
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
